Non-small Cell Lung Cancer
Can telemedicine palliate patients with NSCLC?
Presented by Dr Joseph Greer (Massachusetts General Hospital Cancer Center, USA) at ASCO 2024, read outcome data from the REACH PC trial for comparing the effectiveness of early palliative care delivered through video with in-person care for patients with advanced NSCLC
Osimertinib for EGFR-mutated NSCLC – LAURA trial
Presented by Dr Suresh S Ramalingam (Winship Cancer Institute of Emory University, USA) at ASCO 2024, read LAURA outcome data for osimertinib for managing unresectable stage 3 EGFR-mutated NSCLC without progression.
ASCO 2024 A high-level overview
From ASCO 2024, read Dr Ben Gallarda’s overview of ASCO’s commitment to palliative care, artificial intelligence, and coordination with organizations.
Symposium on refractory multiple myeloma, COMy 2023
Watch our expert panel discussion on the management of relapsed and refractory multiple myeloma (RRMM) in older and frail adults.
How can poor-quality clinical trials impact clinical decision-making?
Explore why a cautious approach is warranted when interpreting trial results.
of interest
are looking at
saved
next event